Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

292 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A comprehensive examination of CYP19 variation and risk of breast cancer using two haplotype-tagging approaches.
Olson JE, Ingle JN, Ma CX, Pelleymounter LL, Schaid DJ, Pankratz VS, Vierkant RA, Fredericksen ZS, Wu Y, Couch FJ, Vachon CM, Sellers TA, Weinshilboum RM. Olson JE, et al. Among authors: ma cx. Breast Cancer Res Treat. 2007 Apr;102(2):237-47. doi: 10.1007/s10549-006-9324-7. Epub 2006 Sep 27. Breast Cancer Res Treat. 2007. PMID: 17004113 Free PMC article.
Human aromatase: gene resequencing and functional genomics.
Ma CX, Adjei AA, Salavaggione OE, Coronel J, Pelleymounter L, Wang L, Eckloff BW, Schaid D, Wieben ED, Adjei AA, Weinshilboum RM. Ma CX, et al. Cancer Res. 2005 Dec 1;65(23):11071-82. doi: 10.1158/0008-5472.CAN-05-1218. Cancer Res. 2005. PMID: 16322257
A comprehensive examination of CYP19 variation and breast density.
Olson JE, Ma CX, Pelleymounter LL, Schaid DJ, Pankratz VS, Vierkant RA, Fredericksen ZS, Ingle JN, Wu Y, Couch F, Sellers TA, Weinshilboum RM, Vachon CM. Olson JE, et al. Among authors: ma cx. Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):623-5. doi: 10.1158/1055-9965.EPI-06-0781. Cancer Epidemiol Biomarkers Prev. 2007. PMID: 17372263 No abstract available.
Treatment-associated musculoskeletal and vasomotor symptoms and relapse-free survival in the NCIC CTG MA.27 adjuvant breast cancer aromatase inhibitor trial.
Stearns V, Chapman JA, Ma CX, Ellis MJ, Ingle JN, Pritchard KI, Budd GT, Rabaglio M, Sledge GW, Le Maitre A, Kundapur J, Liedke PE, Shepherd LE, Goss PE. Stearns V, et al. Among authors: ma cx. J Clin Oncol. 2015 Jan 20;33(3):265-71. doi: 10.1200/JCO.2014.57.6926. Epub 2014 Dec 15. J Clin Oncol. 2015. PMID: 25512454 Free PMC article. Clinical Trial.
Letrozole in the neoadjuvant setting: the P024 trial.
Ellis MJ, Ma C. Ellis MJ, et al. Breast Cancer Res Treat. 2007;105 Suppl 1(Suppl 1):33-43. doi: 10.1007/s10549-007-9701-x. Epub 2007 Oct 3. Breast Cancer Res Treat. 2007. PMID: 17912634 Free PMC article. Clinical Trial.
Phase II trial of temsirolimus in patients with metastatic breast cancer.
Fleming GF, Ma CX, Huo D, Sattar H, Tretiakova M, Lin L, Hahn OM, Olopade FO, Nanda R, Hoffman PC, Naughton MJ, Pluard T, Conzen SD, Ellis MJ. Fleming GF, et al. Among authors: ma cx. Breast Cancer Res Treat. 2012 Nov;136(2):355-63. doi: 10.1007/s10549-011-1910-7. Epub 2012 Jan 13. Breast Cancer Res Treat. 2012. PMID: 22245973 Free PMC article. Clinical Trial.
Racial differences in outcomes of triple-negative breast cancer.
Pacheco JM, Gao F, Bumb C, Ellis MJ, Ma CX. Pacheco JM, et al. Among authors: ma cx. Breast Cancer Res Treat. 2013 Feb;138(1):281-9. doi: 10.1007/s10549-012-2397-6. Epub 2013 Feb 12. Breast Cancer Res Treat. 2013. PMID: 23400579 Free PMC article.
292 results